.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A meta-analysis of randomized controlled trials provides a useful evidence base for the ongoing debate over operative versus nonoperative management of displaced midshaft clavicle fractures. Across six randomized trials involving more than 600 patients, plate fixation substantially reduced nonunion risk compared with nonoperative care. It also produced modestly better Constant and DASH scores at one year. However, when routine implant-removal operations were counted, the total burden of secondary surgery was not clearly lower with fixation. This distinction is important in counselling patients. Plate fixation can provide a more predictable route to union and may be attractive for patients with substantial displacement, high functional demand or concern about symptomatic nonunion. At the same time, surgery introduces wound, implant and hardware-removal risks. The evidence therefore does not support routine fixation for every displaced midshaft fracture. Clinical context matters: the fracture pattern, degree of shortening, skin condition, occupation, sport and patient preference should all contribute to the decision. For HCPs, the key message is that surgery improves union probability more consistently than it improves long-term function. A patient-centred discussion should make that trade-off explicit.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A meta-analysis of randomized controlled trials provides a useful evidence base for the ongoing debate over operative versus nonoperative management of displaced midshaft clavicle fractures. Across six randomized trials involving more than 600 patients, plate fixation substantially reduced nonunion risk compared with nonoperative care. It also produced modestly better Constant and DASH scores at one year. However, when routine implant-removal operations were counted, the total burden of secondary surgery was not clearly lower with fixation. This distinction is important in counselling patients. Plate fixation can provide a more predictable route to union and may be attractive for patients with substantial displacement, high functional demand or concern about symptomatic nonunion. At the same time, surgery introduces wound, implant and hardware-removal risks. The evidence therefore does not support routine fixation for every displaced midshaft fracture. Clinical context matters: the fracture pattern, degree of shortening, skin condition, occupation, sport and patient preference should all contribute to the decision. For HCPs, the key message is that surgery improves union probability more consistently than it improves long-term function. A patient-centred discussion should make that trade-off explicit.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
